Medical Genetics in Ophthalmology: Through the Lens of Genetics-Informed Therapies OnDemand
Availability
On-Demand
Release on Mar 23, 2026 12:00 AM Central Daylight Time
Expires on Mar 31, 2028
Cost
ACMG Member: $150.00
Non-Member: $200.00
Postdoc/Trainee (M): $125.00
Postdoc/Trainee (NM): $170.00
Student (M): $100.00
Student (NM): $135.00
Credit Offered
3.5 CME (AMA) Credits
3.5 CME (Other) Credits

  

Date of Release: March 23, 2026

Expiration Date: March 31, 2028

ASCLS P.A.C.E.® Expiration Date: March 31, 2027

Credits offered: AMA PRA Category 1 Credits™, ASCLS P.A.C.E.®, NSGC (Pending)

Estimate time of completion: 3.5 hours

 

Medical Genetics in Ophthalmology: Through the Lens of Genetics-Informed Therapies

 

Description

Ophthalmic genetics is a well-established field for management, diagnosis, and counseling of rare genetic eye disorders and genetic systemic disorders with eye manifestations in children and adults. Multiple clinical models and training pathways are available for medical geneticists, ophthalmologists and genetic counselors interested in this career specialty. This workshop aims to provide a description of the clinical landscape of ophthalmic genetics, unique diagnostic and therapeutic challenges, including highlighting the growing field of gene-targeted and gene-agnostic therapies. Participants will gain insight into training, clinical phenotyping, including advanced multimodal imaging, genetic testing, and gene therapy considerations, as well as the opportunity to interact with leaders in ophthalmic genetics clinical and translational research. We will provide an open forum for clinical geneticists and ophthalmologists to present cases which remain unsolved or represent an example of the power of ocular genetics.

Target Audience

ACMG members, medical geneticists, laboratory geneticists, genetic counselors, ophthalmologists with experience in genetics practice, and ophthalmologists with interest in genetics training.

 

Learning Objectives

At the conclusion of this session, participants should be able to:

  • Define key ophthalmic terms used in genetic diagnosis.
  • Distinguish between common congenital ocular anomalies and their genetic implications.
  • Recognize how precise terminology improves communication between medical geneticists and ophthalmologists.
  • Describe current training pathways integrating genetics and ophthalmology.
  • Compare educational approaches for ophthalmologists, medical geneticists, and genetic counselors.
  • Identify strategies to develop genetics-focused training within ophthalmology programs.
  • Explain the essential components of a multidisciplinary ophthalmic genetics clinic.
  • Differentiate between genetic testing modalities used in ocular disease diagnosis.
  • Evaluate approaches for selecting appropriate clinical, research, or sponsored testing.
  • Summarize current and emerging gene therapy options for ocular genetic disease.
  • Discuss gene-directed and gene-agnostic therapeutic approaches.
  • Examine the patient experience and ethical considerations surrounding ocular gene therapy.

Category

Member Fee

Non-Member Fee

Professional

$150

$200

Postdoc/Trainee

$125

$170

Student

$100

$135

Opening Remarks & Session 1 — The Importance of Proper Eye Terminology in Genetic Diagnosis

Session 2 — Pathways for Genetics Training and Education in Ophthalmology

Session 3-  The Role of Multidisciplinary Clinics in the Gene Therapy Era

Session 4 - Therapeutic Options for Ocular Genetic Disease and the Medical Geneticist

no image

Alex Levin, MD, MS

University of Rochester Medical Center

no image

Tomas Aleman, MD

University of Pennsylvania- Perelman School of Medicine

no image

Gavin Arno

Greenwood Genetic Center

 

no image

Brian Brooks, MD, PhD

Ophthalmic Genetics & Visual Function, National Eye Institute

 

no image

Peter Campochiaro, MD

Johns Hopkins Hospital School of Medicine

 

no image

Amy Laster, BS, PhD

The Foundation Fighting Blindness

 

no image

Kristy Lee, MS

University of North Carolina at Chapel Hill

 

no image

Lev Prasov, MD

Departments of Ophthalmology and Visual Sciences and Human Genetics, NIH

 

no image

Eric Pierce, MD, PhD

Harvard Medical School

 

no image

Anne Slavotinek, MBBS, PhD, FACMG

Cincinnati Children's Hospital Medical Center

 

no image

Elias Traboulsi, MD, MEd

Cleveland Clinic Cole Eye Institute

 

no image

David Valle, MD, FACMG

Johns Hopkins University School of Medicine

 

 

no image

Celeste Wyman, ScM, CGC

Flaum Eye Institute (URMC)

 

Accredited Continuing Education Information:

CME AMA PRA Category 1 CreditsTM, ASCLS P.A.C.E.®, NSGC (Pending)

 

Accreditation

The American College of Medical Genetics and Genomics is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

 

Credit Designation

The American College of Medical Genetics and Genomics designates this enduring activity for a maximum of 3.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

The American Medical Association (AMA) defines physicians as those individuals who have obtained an MD, DO, or equivalent medical degree from another country. Non-physicians may request a certificate of attendance for their participation.

 

ASCLS P.A.C.E.® CEU's 

ACMG is approved as a provider of continuing education programs in the clinical laboratory sciences by the American Society for Clinical Laboratory Science (ASCLS) Professional Acknowledgment for Continuing Education (P.A.C.E.®) Program.

 

ACMG is approved by the Florida Board of Clinical Laboratory Personnel as CE Provider (50-11878). This course is registered with CEBroker #20-1332029. ACMG is approved by the California Department of Health Services through the ASCLS P.A.C.E.® (275-100-26). This activity has been approved for 0.35 P.A.C.E.® CEU's.

National Society of Genetic Counselors (NSGC):

This event has been submitted to the National Society of Genetic Counselors (NSGC) for approval of Category 1 CEUs. The American Board of Genetic Counseling (ABGC) accepts CEUs approved by NSGC for purposes of recertification. Approval for the requested CEUs and contact hours is currently pending.

Claiming your Educational Credits

This activity consists of: View content, take a post-test, the test may be taken as often as necessary to achieve a passing score of 80% or better is required to receive credit.  If you do not achieve a passing score, the program will identify which questions you answered incorrectly so that you can review the module and try again. Complete the evaluation form.

Learner Data Consent

ACMG Education reports learner data to respective agency boards and you will be asked for consent during the evaluation process. Your compliance with deadlines and completing evaluations are part of the process in meeting learner needs and ACMG’s education mission.

 

Technical Support:
You can reach us by email at
education@acmg.net or call 301-718-9603.
Support Center Hours: Monday – Friday, 9:00 AM – 5:00 PM Eastern Time.

© American College of Medical Genetics and Genomics. All rights reserved.

Powered By